IL6 and neoplasm: The presence of tumor cells was sufficient to upregulate several other pro-inflammatory cytokines and chemokines, including tumor necrosis factor alpha, IL-6, chemokine C-C motif ligand 3 (CCL3), and CCL4, regardless of anti-PD-L1 treatment (Figure 4C).